Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.

Remote Patient Monitoring Device Found Effective for Early Detection of Medical Deterioration

Remote Patient Monitoring Device
Study results have demonstrated the device’s efficacy among at-risk patients

As part of a recent Sheba study, an advanced wearable remote patient monitoring device has demonstrated efficacy in more quickly identifying patients at risk of deterioration compared to traditional monitoring methods. 

The study included 217 hospitalized patients with a median age of 71, of whom 59.9% were male. Participants were equipped with wearable RPM devices, which calculated scores indicating their condition every five minutes according to three models: the National Early Warning Score (NEWS), the Airway, Breathing, Circulation, Neurology, and Other, as well as the clinical team’s deterioration ‘Wish List’ criteria.

Researchers confirmed clinical deterioration in 24 out of the 217 patients. With respect to these 24 patients, the NEWS model indicated high alert in 16, ABNCO in 18, and ‘Wish List’ in all of the 24.

On top of detecting each case of clinical deterioration, The RPM wearable devices did so 29-40 hours faster compared to standard monitoring methods.

“This study shows that disruptive telehealth can provide viable alternatives to clinical deterioration detection by medical staff,” Says Prof. Gal Segal, Head of Internal Medicine at the Sheba Beyond Virtual Hospital and Principal Investigator of the study. “The output signals from remote monitoring can be equivalent to medical-grade ICU monitoring, and that opens up possibilities for home hospitalization, in line with Beyond’s vision of supporting the global transition to telemedicine.” 

Breakthrough Research
News Jun 05.
Breakthrough Research Provides Pancreatic Cancer Patients with New Hope
Pancreatic cancer is a significant cause of cancer-related death, standing at fourth place globally. It is also the twelfth most common cancer type worldwide, with…
Read More
Sheba Study in collaboration with other medical institutions found an effective way of treatment, a type of cure for hemophilia.
News Jun 05.
Groundbreaking Sheba Study Indicates: New Gene Therapy Offers Rapid Cure for Hemophilia 
Hemophilia is a bleeding disorder that stems from a genetic mutation or alteration in the genes that encode clotting factor proteins, which are necessary for…
Read More
Sheba and Mayo Clinic merge Data-Sharing Network
News May 18.
Sheba and Mayo Clinic Partner to Transform Patient Care Through an Innovative Data-Sharing Network
Sheba Medical Center has joined the Mayo Clinic Platform Connect, a global data-sharing network that aims to revolutionize healthcare. The groundbreaking platform provides a safe,…
Read More